137 related articles for article (PubMed ID: 25870848)
1. Reliability Evaluation of Fluorescence In Situ Hybridization (FISH) and G-Banding on Bone Marrow and Peripheral Blood Cells in Chronic Myelogenous Leukemia Patients.
Manaflouyan Khajehmarjany S; Rahmani SA; Chavoshi SH; Esfahani A; Movassaghpour Akbari AA
Cell J; 2015; 17(1):171-80. PubMed ID: 25870848
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment.
Mühlmann J; Thaler J; Hilbe W; Bechter O; Erdel M; Utermann G; Duba HC
Genes Chromosomes Cancer; 1998 Feb; 21(2):90-100. PubMed ID: 9491319
[TBL] [Abstract][Full Text] [Related]
4. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis.
Cuneo A; Bigoni R; Emmanuel B; Smit E; Rigolin GM; Roberti MG; Bardi A; Piva N; Scapoli G; Castoldi G; Van Den Berghe H; Hagemeijer A
Leukemia; 1998 Nov; 12(11):1718-23. PubMed ID: 9823946
[TBL] [Abstract][Full Text] [Related]
6. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
7. [Detection of Bcr/Abl gene rearrangement in chronic myelogenous leukemia patients by dual-color dual-fusion fluorescence in situ hybridization].
Guo B; Zhu HL; Li SX; Lu XC; Fan H; Zhao DD; Han XP; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):261-5. PubMed ID: 19379547
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
9. Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
Lee YK; Lee DW; Kim YL; Lee S; Min CK; Kim YJ; Oh IH; Kim TG; Kim CC; Kim DW
Int J Hematol; 2002 Aug; 76(2):180-5. PubMed ID: 12215018
[TBL] [Abstract][Full Text] [Related]
10. Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens.
Werner M; Ewig M; Nasarek A; Wilkens L; von Wasielewski R; Tchinda J; Nolte M
Diagn Mol Pathol; 1997 Oct; 6(5):282-7. PubMed ID: 9458387
[TBL] [Abstract][Full Text] [Related]
11. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.
Fugazza G; Miglino M; Bruzzone R; Quintino S; Gatti AM; Grasso R; Gobbi M; Frassoni F; Sessarego M
J Exp Clin Cancer Res; 2004 Jun; 23(2):295-9. PubMed ID: 15354415
[TBL] [Abstract][Full Text] [Related]
13. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy.
Takahashi N; Miura I; Kobayashi Y; Kume M; Yoshioka T; Otane W; Ohtsubo K; Takahashi K; Kitabayashi A; Kawabata Y; Hirokawa M; Nishijima H; Ichinohasama R; Decoteau J; Miura AB; Sawada K
Int J Hematol; 2005 Apr; 81(3):235-41. PubMed ID: 15814334
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia.
Kobzev Y; Domracheva E; Zakharova A; Khoroshko N; Turkina A; Dewald G
Cancer Genet Cytogenet; 1998 Oct; 106(2):128-34. PubMed ID: 9797777
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
Jha CB; Kucheria K; Choudhary VP
Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].
Pan CY; Xu N; He BL; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Sun J; Feng R; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):112-117. PubMed ID: 28279034
[No Abstract] [Full Text] [Related]
18. [Detection of BCR/ABL fusion gene by fluorescence in situ hybridization and its clinical application].
Zhou RL; Mo YX; Lan M; Lin JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1283-8. PubMed ID: 22040989
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation.
Nolte M; Werner M; Ewig M; von Wasielewski R; Wilkens L; Link H; Ganser A; Georgii A
Leuk Lymphoma; 1996 Jul; 22(3-4):287-94. PubMed ID: 8819078
[TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
Morris CM
Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
